MeiraGTx Holdings (MGTX) Exchange Rate Effect (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Exchange Rate Effect came in at $217000.0 in Q4 2025, down 75.59% YoY from $889000.0 in Q4 2024, and up 105.0% on a QoQ basis from -$4.3 million in Q3 2025.
Powered by 
Analysis
MeiraGTx Holdings (MGTX) Exchange Rate Effect (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Exchange Rate Effect data on file, last reported at $217000.0 in Q4 2025.
- Quarterly Exchange Rate Effect fell 75.59% year-over-year to $217000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $719000.0 (down 52.1% YoY) and the FY2025 annual result came in at $719000.0, down 52.1% from the prior year.
- Exchange Rate Effect climbed to $217000.0 in Q4 2025, from -$4.3 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $5.1 million in Q2 2025 to a low of -$4.3 million in Q3 2025.
- A 5-year average of $202850.0 and a median of $123500.0 in 2021 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 8844.83% in 2025, down 1232.38% in 2025.
- Tracing MGTX's Exchange Rate Effect over 5 years: stood at -$685000.0 in 2021, then jumped by 207.45% to $736000.0 in 2022, then surged by 158.7% to $1.9 million in 2023, then slumped by 53.31% to $889000.0 in 2024, then plunged by 75.59% to $217000.0 in 2025.
- The last three Exchange Rate Effect figures came in at $217000.0 (Q4 2025), -$4.3 million (Q3 2025), and $5.1 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 217,000.00 |
| Sep 30, 2025 | -4.34 Mn |
| Jun 30, 2025 | 5.07 Mn |
| Mar 31, 2025 | -233,000.00 |
| Dec 31, 2024 | 889,000.00 |
| Sep 30, 2024 | 383,000.00 |
| Jun 30, 2024 | -58,000.00 |
| Mar 31, 2024 | 287,000.00 |
| Dec 31, 2023 | 1.90 Mn |
| Sep 30, 2023 | 12,000.00 |
| Jun 30, 2023 | 29,000.00 |
| Mar 31, 2023 | 496,000.00 |
| Dec 31, 2022 | 736,000.00 |
| Sep 30, 2022 | 386,000.00 |
| Jun 30, 2022 | 134,000.00 |
| Mar 31, 2022 | -582,000.00 |
| Dec 31, 2021 | -685,000.00 |
| Sep 30, 2021 | 113,000.00 |
| Jun 30, 2021 | -242,000.00 |
| Mar 31, 2021 | -464,000.00 |